Generalized anxiety disorder: Prevalence, predictors, and comorbidity in children and adolescents

共病 情感障碍和精神分裂症时间表 广泛性焦虑症 全国共病调查 精神科 焦虑症 焦虑 心理学 逻辑回归 临床心理学 情绪障碍 医学 内科学
作者
Mohammad Reza Mohammadi,Parandis Pourdehghan,Seyed‐Ali Mostafavi,Zahra Hooshyari,Nastaran Ahmadi,Ali Khaleghi
出处
期刊:Journal of Anxiety Disorders [Elsevier BV]
卷期号:73: 102234-102234 被引量:46
标识
DOI:10.1016/j.janxdis.2020.102234
摘要

Generalized anxiety disorder (GAD) is one of the most prevalent anxiety disorders among children and adolescents. The purpose of this study is to determine the prevalence, sociodemographic variables, and comorbidity of GAD among children and adolescents to suggest the main predictors, using an analytical cross-sectional study. Data were collected via a multistage random-cluster sampling method from 29,709 children and adolescents aged 6–18 years old in Iran. We used the Persian present and lifetime version of the Kiddie Schedule for Affective Disorders and Schizophrenia (K-SADS-PL). Then, we analyzed the data via descriptive analysis and multivariate logistic regression analysis methods. The lifetime prevalence rate for GAD was 2.6 % (95 % Cl, 2.4%–2.8%). Overall, logistic regression analyses revealed five variables with significant unique contributions to the prediction of GAD. Significant predictors were: age, sex, mother history of psychiatric hospitalization, mother education, and residence. Participants with these risk factors were between 0.23–2.91 times more likely to present with GAD. Besides, the highest and lowest comorbidity rates of psychiatric disorder with GAD was 57.6 % and 0.3 % related to anxiety and eating disorders, respectively. Age or sex also affects the comorbidity of GAD and some mental disorders including behavioral, neurodevelopmental, elimination, and mood disorders. This study, which was conducted in Iran, is located at the low end of the range of international estimates for GAD. Awareness of the predictors and comorbidity of GAD could be used in the prevention of GAD in children and adolescents.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
ads完成签到,获得积分10
刚刚
热心的蚂蚁完成签到,获得积分10
刚刚
可爱的函函应助neversay4ever采纳,获得10
刚刚
自觉谷南发布了新的文献求助50
刚刚
小闫完成签到,获得积分10
刚刚
刚刚
hhhhhh发布了新的文献求助10
1秒前
优雅翎完成签到,获得积分10
1秒前
1917完成签到,获得积分10
1秒前
情怀应助平常心采纳,获得10
1秒前
1秒前
1秒前
ioi发布了新的文献求助10
1秒前
凛夜发布了新的文献求助10
2秒前
宋成为发布了新的文献求助10
2秒前
派大星完成签到,获得积分10
2秒前
夜包子123完成签到,获得积分10
2秒前
科研通AI6.4应助HM采纳,获得10
3秒前
YYCBNU发布了新的文献求助30
3秒前
PSC完成签到,获得积分10
3秒前
荔枝完成签到,获得积分10
3秒前
3秒前
3秒前
4秒前
4秒前
欣喜冰萍发布了新的文献求助10
5秒前
orixero应助许健采纳,获得10
5秒前
5秒前
守望者发布了新的文献求助10
5秒前
迅速紫伊发布了新的文献求助10
6秒前
梅川库子完成签到,获得积分10
6秒前
wanci应助之予无为采纳,获得10
6秒前
Owen应助荔枝采纳,获得10
6秒前
6秒前
cdercder应助ttt采纳,获得10
7秒前
勤劳冰安发布了新的文献求助10
7秒前
江姜酱先生完成签到,获得积分10
7秒前
木棉发布了新的文献求助10
7秒前
wendy完成签到,获得积分20
8秒前
Orange应助drfy123采纳,获得10
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Prompt Engineering for Clinicians: Harnessing AI in Everyday Medical Practice 600
University Physics for the Life Sciences 500
REAL-WORLD EFFICACY AND GENOMIC LANDSCAPE OF POLATUZUMA VEDOTIN-BASED FIRST-LINE THERAPY IN DIFFUSE LARGE B-CELL LYMPHOMA: A FOCUS ON TP53 MUTATIONS AND TREATMENT RESPONSE 500
Handbook of Luminescence Dating 500
Safety Pharmacology 500
《KNN基无铅压电陶瓷电学性能优化与物理机理研究》 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 计算机科学 化学工程 生物化学 物理 内科学 复合材料 催化作用 光电子学 物理化学 电极 细胞生物学 基因 遗传学
热门帖子
关注 科研通微信公众号,转发送积分 6953073
求助须知:如何正确求助?哪些是违规求助? 8637024
关于积分的说明 18315184
捐赠科研通 6396547
什么是DOI,文献DOI怎么找? 3082634
关于科研通互助平台的介绍 2128415
邀请新用户注册赠送积分活动 2059568